CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: adefovir
Accession: CHEBI:2469
browse the term
Definition: A member of the class of phosphonic acids that is methylphosphonic acid in which one of the methyl hydrogens has been replaced by a 2-(6-amino-9H-purin-9-yl)ethoxy group. An inhibitor of HIV-1 reverse transcriptase, the bis(t-butoxycarbonyloxymethyl) ester (dipivoxil ester) prodrug is used to treat chronic hepatitis B viral infection.
Synonyms: exact_synonym: {[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}phosphonic acid
related_synonym: 9-(2-(Phosphonomethoxy)ethyl)adenine; 9-(2-Phosphonylmethoxyethyl)adenine; DRG-0156; Formula=C8H12N5O4P; GS 0393; GS 393; HSDB 8079; InChI=1S/C8H12N5O4P/c9-7-6-8(11-3-10-7)13(4-12-6)1-2-17-5-18(14,15)16/h3-4H,1-2,5H2,(H2,9,10,11)(H2,14,15,16); InChIKey=SUPKOOSCJHTBAH-UHFFFAOYSA-N; N-(2-Phosphonylmethoxyethyl)adenine; PMEA; SMILES=N1(C2=C(C(N)=NC=N2)N=C1)CCOCP(O)(=O)O
alt_id: CHEBI:40188
xref: Beilstein:3561094; CAS:106941-25-7; DrugBank:DB00718; KEGG:C11277; KEGG:D02768
xref_mesh: MESH:C053001
xref: PDBeChem:5HG; PMID:10676990; PMID:11796353; PMID:14647052; PMID:14978283; PMID:15866657; PMID:22976988; PMID:24338503; PMID:27079793; PMID:27381944; PMID:27649318; PMID:27664568; PMID:27698751; PMID:27729626; PMID:27746441; PMID:27806120; PMID:27858892; PMID:27880997; PMID:27977591; PMID:28011962; PMID:28079295; PMID:28081595; PMID:28123560; PMID:28322924; PMID:28397817; PMID:28436380; Reaxys:3561094; Wikipedia:Adefovir
cyclic_relationship: is_conjugate_acid_of CHEBI:134512
G
Abcb4
ATP binding cassette subfamily B member 4
multiple interactions affects transport
EXP
Calcitriol promotes the reaction [ABCB4 protein affects the transport of adefovir]
CTD
PMID:21240898 PMID:21341280
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Abcc4
ATP binding cassette subfamily C member 4
affects abundance multiple interactions decreases expression increases export
ISO EXP
ABCC4 protein affects the abundance of adefovir [adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] affects the expression of ABCC4 protein; [adefovir co-treated with Probenecid co-treated with Valsartan] affects the expression of ABCC4 protein; [adefovir co-treated with Probenecid] results in decreased expression of ABCC4 protein adefovir results in decreased expression of ABCC4 protein ABCC4 protein results in increased export of adefovir
CTD
PMID:18364470 PMID:35114312
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Acta2
actin alpha 2, smooth muscle
increases expression multiple interactions
EXP
adefovir results in increased expression of ACTA2 protein [adefovir co-treated with Probenecid] results in increased expression of ACTA2 protein; Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of ACTA2 protein]; Valsartan inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of ACTA2 protein]
CTD
PMID:35114312
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Agt
angiotensinogen
multiple interactions
EXP
[Probenecid co-treated with adefovir] results in increased expression of AGT protein; [Probenecid co-treated with Valsartan co-treated with adefovir] results in increased expression of AGT protein; Cromolyn Sodium inhibits the reaction [[Probenecid co-treated with adefovir] results in increased expression of AGT protein]
CTD
PMID:35114312
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
B2m
beta-2 microglobulin
increases secretion
EXP
adefovir results in increased secretion of B2M protein
CTD
PMID:27742868
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
Calb1
calbindin 1
increases secretion
EXP
adefovir results in increased secretion of CALB1 protein
CTD
PMID:27742868
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
G
Cma1
chymase 1
increases secretion
EXP
adefovir results in increased secretion of CMA1 protein
CTD
PMID:35114312
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
G
Cst3
cystatin C
multiple interactions increases expression
EXP
[adefovir co-treated with Probenecid] results in increased expression of CST3 protein; [Probenecid co-treated with Valsartan co-treated with adefovir] results in increased expression of CST3 protein; [Probenecid co-treated with Valsartan] inhibits the reaction [adefovir results in increased expression of CST3 protein]; Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of CST3 protein]
CTD
PMID:35114312
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Havcr1
hepatitis A virus cellular receptor 1
increases secretion
EXP
adefovir results in increased secretion of HAVCR1 protein
CTD
PMID:27742868
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Lcn2
lipocalin 2
increases secretion
EXP
adefovir results in increased secretion of LCN2 protein
CTD
PMID:27742868
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Mmut
methylmalonyl-CoA mutase
affects expression increases expression
ISO
adefovir affects the expression of MMUT mRNA mutant form; adefovir affects the expression of MMUT protein mutant form adefovir results in increased expression of MMUT mRNA; adefovir results in increased expression of MMUT protein
CTD
PMID:19199343 PMID:19427250
NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
G
Slc22a6
solute carrier family 22 member 6
increases uptake multiple interactions decreases expression affects response to substance increases response to substance
EXP ISO
SLC22A6 protein results in increased uptake of adefovir [adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] affects the expression of SLC22A6 protein; [adefovir co-treated with Probenecid co-treated with Valsartan] affects the expression of SLC22A6 protein; [adefovir co-treated with Probenecid] results in decreased expression of SLC22A6 protein; Valsartan inhibits the reaction [[adefovir co-treated with Probenecid] results in decreased expression of SLC22A6 protein] adefovir results in decreased expression of SLC22A6 protein SLC22A6 protein affects the susceptibility to adefovir adefovir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]; Probenecid inhibits the reaction [SLC22A6 protein results in increased susceptibility to adefovir]; quercetin 3'-sulfate inhibits the reaction [SLC22A6 protein affects the susceptibility to adefovir]; SLC22A6 protein results in increased uptake of and results in increased susceptibility to adefovir
CTD
PMID:16857889 PMID:21244849 PMID:23856525 PMID:25448811 PMID:35114312
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
increases response to substance multiple interactions decreases expression
ISO EXP
SLC22A8 protein results in increased susceptibility to adefovir [adefovir co-treated with Probenecid co-treated with Cromolyn Sodium] results in increased expression of SLC22A8 protein; [adefovir co-treated with Probenecid co-treated with Valsartan] results in increased expression of SLC22A8 protein; [adefovir co-treated with Probenecid] results in decreased expression of SLC22A8 protein; Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in decreased expression of SLC22A8 protein] adefovir results in decreased expression of SLC22A8 protein
CTD
PMID:25448811 PMID:35114312
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Spp1
secreted phosphoprotein 1
increases secretion
EXP
adefovir results in increased secretion of SPP1 protein
CTD
PMID:27742868
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Tgfb1
transforming growth factor, beta 1
increases expression multiple interactions
EXP
adefovir results in increased expression of TGFB1 protein [adefovir co-treated with Probenecid] results in increased expression of TGFB1 protein; Cromolyn Sodium inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of TGFB1 protein]; Valsartan inhibits the reaction [[adefovir co-treated with Probenecid] results in increased expression of TGFB1 protein]
CTD
PMID:35114312
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Ahr
aryl hydrocarbon receptor
affects activity
ISO
adefovir dipivoxil affects the activity of AHR protein
CTD
PMID:25596134
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ak4
adenylate kinase 4
increases expression
ISO
adefovir dipivoxil results in increased expression of AK4 mRNA
CTD
PMID:25596134
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Akr1c2
aldo-keto reductase family 1, member C2
decreases expression
ISO
adefovir dipivoxil results in decreased expression of AKR1C2 mRNA
CTD
PMID:25596134
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of ALDH18A1 mRNA
CTD
PMID:25596134
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
G
Aldh1a3
aldehyde dehydrogenase 1 family, member A3
increases expression
ISO
adefovir dipivoxil results in increased expression of ALDH1A3 mRNA
CTD
PMID:25596134
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
G
Als2cl
ALS2 C-terminal like
increases expression
ISO
adefovir dipivoxil results in increased expression of ALS2CL mRNA
CTD
PMID:25596134
NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419
G
Angptl4
angiopoietin-like 4
increases expression
ISO
adefovir dipivoxil results in increased expression of ANGPTL4 mRNA
CTD
PMID:25596134
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
decreases expression
ISO
adefovir dipivoxil results in decreased expression of ASNS mRNA
CTD
PMID:25596134
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Atad2
ATPase family, AAA domain containing 2
increases expression
ISO
adefovir dipivoxil results in increased expression of ATAD2 mRNA
CTD
PMID:25596134
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
G
Atf3
activating transcription factor 3
increases expression
ISO
adefovir dipivoxil results in increased expression of ATF3 mRNA
CTD
PMID:25596134
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Aurkb
aurora kinase B
increases expression
ISO
adefovir dipivoxil results in increased expression of AURKB mRNA
CTD
PMID:25596134
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Axl
Axl receptor tyrosine kinase
increases expression
ISO
adefovir dipivoxil results in increased expression of AXL mRNA
CTD
PMID:25596134
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
adefovir dipivoxil results in increased expression of BAX mRNA
CTD
PMID:25596134
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcar3
BCAR3 adaptor protein, NSP family member
increases expression
ISO
adefovir dipivoxil results in increased expression of BCAR3 mRNA
CTD
PMID:25596134
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
G
Bend5
BEN domain containing 5
decreases expression
ISO
adefovir dipivoxil results in decreased expression of BEND5 mRNA
CTD
PMID:25596134
NCBI chr 5:126,290,648...126,336,662
Ensembl chr 5:125,254,956...126,534,367
G
Bmf
Bcl2 modifying factor
decreases expression
ISO
adefovir dipivoxil results in decreased expression of BMF mRNA
CTD
PMID:25596134
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
adefovir dipivoxil results in increased expression of BTG2 mRNA
CTD
PMID:25596134
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Ccne2
cyclin E2
increases expression
ISO
adefovir dipivoxil results in increased expression of CCNE2 mRNA
CTD
PMID:25596134
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Cdk6
cyclin-dependent kinase 6
increases expression
ISO
adefovir dipivoxil results in increased expression of CDK6 mRNA
CTD
PMID:25596134
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
adefovir dipivoxil results in increased expression of CDKN1A mRNA
CTD
PMID:25596134
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cmbl
carboxymethylenebutenolidase homolog
increases expression
ISO
adefovir dipivoxil results in increased expression of CMBL mRNA
CTD
PMID:25596134
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
G
Coch
cochlin
increases expression
ISO
adefovir dipivoxil results in increased expression of COCH mRNA
CTD
PMID:25596134
NCBI chr 6:69,031,139...69,045,124
Ensembl chr 6:69,031,167...69,045,109
G
Col4a1
collagen type IV alpha 1 chain
decreases expression
ISO
adefovir dipivoxil results in decreased expression of COL4A1 mRNA
CTD
PMID:25596134
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
G
Cth
cystathionine gamma-lyase
decreases expression
ISO
adefovir dipivoxil results in decreased expression of CTH mRNA
CTD
PMID:25596134
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctsc
cathepsin C
decreases expression
ISO
adefovir dipivoxil results in decreased expression of CTSC mRNA
CTD
PMID:25596134
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
adefovir dipivoxil results in increased expression of CYP1B1 mRNA
CTD
PMID:25596134
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity
ISO
adefovir dipivoxil results in decreased activity of CYP3A4 protein
CTD
PMID:17162464
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Ddb2
damage specific DNA binding protein 2
increases expression
ISO
adefovir dipivoxil results in increased expression of DDB2 mRNA
CTD
PMID:25596134
NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:77,185,109...77,207,631
G
Dgka
diacylglycerol kinase, alpha
increases expression
ISO
adefovir dipivoxil results in increased expression of DGKA mRNA
CTD
PMID:25596134
NCBI chr 7:1,148,734...1,175,324
Ensembl chr 7:1,148,735...1,175,110
G
Dlgap5
DLG associated protein 5
increases expression
ISO
adefovir dipivoxil results in increased expression of DLGAP5 mRNA
CTD
PMID:25596134
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dlx1
distal-less homeobox 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of DLX1 mRNA
CTD
PMID:25596134
NCBI chr 3:56,356,190...56,360,780
Ensembl chr 3:56,356,190...56,360,780
G
Dnai3
dynein axonemal intermediate chain 3
increases expression
ISO
adefovir dipivoxil results in increased expression of DNAI3 mRNA
CTD
PMID:25596134
NCBI chr 2:234,947,910...235,006,173
Ensembl chr 2:234,929,677...235,006,173
G
Dpysl3
dihydropyrimidinase-like 3
increases expression
ISO
adefovir dipivoxil results in increased expression of DPYSL3 mRNA
CTD
PMID:25596134
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
G
Efna1
ephrin A1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of EFNA1 mRNA
CTD
PMID:25596134
NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
increases expression
ISO
adefovir dipivoxil results in increased expression of ERO1A mRNA
CTD
PMID:25596134
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
G
Fas
Fas cell surface death receptor
increases expression
ISO
adefovir dipivoxil results in increased expression of FAS mRNA
CTD
PMID:25596134
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fbxo22
F-box protein 22
increases expression
ISO
adefovir dipivoxil results in increased expression of FBXO22 mRNA
CTD
PMID:25596134
NCBI chr 8:55,579,906...55,595,981
Ensembl chr 8:55,579,891...55,596,148
G
Gabarapl1
GABA type A receptor associated protein like 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of GABARAPL1 mRNA
CTD
PMID:25596134
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
adefovir dipivoxil results in increased expression of GADD45A mRNA
CTD
PMID:25596134
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Galnt16
polypeptide N-acetylgalactosaminyltransferase 16
decreases expression
ISO
adefovir dipivoxil results in decreased expression of GALNT16 mRNA
CTD
PMID:25596134
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
adefovir dipivoxil results in increased expression of GCNT3 mRNA
CTD
PMID:25596134
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gdf15
growth differentiation factor 15
increases expression
ISO
adefovir dipivoxil results in increased expression of GDF15 mRNA
CTD
PMID:25596134
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Got1
glutamic-oxaloacetic transaminase 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of GOT1 mRNA
CTD
PMID:25596134
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gpr87
G protein-coupled receptor 87
increases expression
ISO
adefovir dipivoxil results in increased expression of GPR87 mRNA
CTD
PMID:25596134
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
G
H1f2
H1.2 linker histone, cluster member
increases expression
ISO
adefovir dipivoxil results in increased expression of H1-2 mRNA
CTD
PMID:25596134
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
Hmox1
heme oxygenase 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of HMOX1 mRNA
CTD
PMID:25596134
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
decreases expression
ISO
adefovir dipivoxil results in decreased expression of HSPA1B mRNA
CTD
PMID:25596134
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Ifng
interferon gamma
multiple interactions
ISO
adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]; adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein]
CTD
PMID:9354585
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il19
interleukin 19
increases secretion
ISO
adefovir dipivoxil results in increased secretion of IL19 protein
CTD
PMID:24714768
NCBI chr13:42,397,715...42,411,637
Ensembl chr13:42,399,138...42,405,473
G
Kat6b
lysine acetyltransferase 6B
decreases expression
ISO
adefovir dipivoxil results in decreased expression of KAT6B mRNA
CTD
PMID:25596134
NCBI chr15:2,638,885...2,811,977
Ensembl chr15:2,639,200...2,812,316
G
Kdm3a
lysine demethylase 3A
decreases expression
ISO
adefovir dipivoxil results in decreased expression of KDM3A mRNA
CTD
PMID:25596134
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
G
Krt15
keratin 15
increases expression
ISO
adefovir dipivoxil results in increased expression of KRT15 mRNA
CTD
PMID:25596134
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
G
Lama3
laminin subunit alpha 3
increases expression
ISO
adefovir dipivoxil results in increased expression of LAMA3 mRNA
CTD
PMID:25596134
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
G
Lcn2
lipocalin 2
increases secretion
ISO
adefovir dipivoxil results in increased secretion of LCN2 protein
CTD
PMID:24714768
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
increases expression
ISO
adefovir dipivoxil results in increased expression of MAP3K8 mRNA
CTD
PMID:25596134
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
adefovir dipivoxil results in increased expression of MDM2 mRNA
CTD
PMID:25596134
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Mxi1
MAX interactor 1, dimerization protein
decreases expression
ISO
adefovir dipivoxil results in decreased expression of MXI1 mRNA
CTD
PMID:25596134
NCBI chr 1:252,323,915...252,383,682
Ensembl chr 1:252,323,303...252,383,681
G
Ncapd2
non-SMC condensin I complex, subunit D2
increases expression
ISO
adefovir dipivoxil results in increased expression of NCAPD2 mRNA
CTD
PMID:25596134
NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020
G
Ninj1
ninjurin 1
increases expression
ISO
adefovir dipivoxil results in increased expression of NINJ1 mRNA
CTD
PMID:25596134
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of NOS2 protein]; adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; adefovir dipivoxil inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein]
CTD
PMID:9354585
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of NQO1 mRNA
CTD
PMID:25596134
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nrep
neuronal regeneration related protein
decreases expression
ISO
adefovir dipivoxil results in decreased expression of NREP mRNA
CTD
PMID:25596134
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Ntpcr
nucleoside-triphosphatase, cancer-related
increases expression
ISO
adefovir dipivoxil results in increased expression of NTPCR mRNA
CTD
PMID:25596134
NCBI chr19:53,701,496...53,715,260
Ensembl chr19:53,695,976...53,715,202
G
P4ha1
prolyl 4-hydroxylase subunit alpha 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of P4HA1 mRNA
CTD
PMID:25596134
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
G
Pank1
pantothenate kinase 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of PANK1 mRNA
CTD
PMID:25596134
NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:232,328,430...232,396,829
G
Pdia5
protein disulfide isomerase family A, member 5
increases expression
ISO
adefovir dipivoxil results in increased expression of PDIA5 mRNA
CTD
PMID:25596134
NCBI chr11:65,272,152...65,359,087
Ensembl chr11:65,272,155...65,359,084
G
Pdlim1
PDZ and LIM domain 1
increases expression
ISO
adefovir dipivoxil results in increased expression of PDLIM1 mRNA
CTD
PMID:25596134
NCBI chr 1:239,042,372...239,091,074
Ensembl chr 1:239,042,385...239,091,076
G
Pgr
progesterone receptor
multiple interactions
ISO
adefovir dipivoxil binds to and results in decreased activity of PGR protein
CTD
PMID:25752796
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Phlda3
pleckstrin homology-like domain, family A, member 3
increases expression
ISO
adefovir dipivoxil results in increased expression of PHLDA3 mRNA
CTD
PMID:25596134
NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
G
Pidd1
p53-induced death domain protein 1
increases expression
ISO
adefovir dipivoxil results in increased expression of PIDD1 mRNA
CTD
PMID:25596134
NCBI chr 1:196,536,815...196,542,808
Ensembl chr 1:196,536,834...196,542,699
G
Pir
pirin
increases expression
ISO
adefovir dipivoxil results in increased expression of PIR mRNA
CTD
PMID:25596134
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Plec
plectin
increases expression
ISO
adefovir dipivoxil results in increased expression of PLEC mRNA
CTD
PMID:25596134
NCBI chr 7:107,887,764...107,949,100
Ensembl chr 7:107,887,764...107,945,467
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
ISO
adefovir dipivoxil results in increased expression of PMAIP1 mRNA
CTD
PMID:25596134
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pparg
peroxisome proliferator-activated receptor gamma
affects activity
ISO
adefovir dipivoxil affects the activity of PPARG protein
CTD
PMID:25596134
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppm1d
protein phosphatase, Mg2+/Mn2+ dependent, 1D
increases expression
ISO
adefovir dipivoxil results in increased expression of PPM1D mRNA
CTD
PMID:25596134
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
G
Prc1
protein regulator of cytokinesis 1
increases expression
ISO
adefovir dipivoxil results in increased expression of PRC1 mRNA
CTD
PMID:25596134
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prdm1
PR/SET domain 1
increases expression
ISO
adefovir dipivoxil results in increased expression of PRDM1 mRNA
CTD
PMID:25596134
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
G
Prkab2
protein kinase AMP-activated non-catalytic subunit beta 2
decreases expression
ISO
adefovir dipivoxil results in decreased expression of PRKAB2 mRNA
CTD
PMID:25596134
NCBI chr 2:185,257,218...185,272,846
Ensembl chr 2:185,257,213...185,269,872
G
Psat1
phosphoserine aminotransferase 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of PSAT1 mRNA
CTD
PMID:25596134
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Rara
retinoic acid receptor, alpha
decreases expression
ISO
adefovir dipivoxil results in decreased expression of RARA mRNA
CTD
PMID:25596134
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rps27l
ribosomal protein S27-like
increases expression
ISO
adefovir dipivoxil results in increased expression of RPS27L mRNA
CTD
PMID:25596134
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
G
Rrm2b
ribonucleotide reductase regulatory TP53 inducible subunit M2B
increases expression
ISO
adefovir dipivoxil results in increased expression of RRM2B mRNA
CTD
PMID:25596134
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
G
Serpinb5
serpin family B member 5
increases expression
ISO
adefovir dipivoxil results in increased expression of SERPINB5 mRNA
CTD
PMID:25596134
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
G
Sesn1
sestrin 1
increases expression
ISO
adefovir dipivoxil results in increased expression of SESN1 mRNA
CTD
PMID:25596134
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
G
Sfn
stratifin
increases expression
ISO
adefovir dipivoxil results in increased expression of SFN mRNA
CTD
PMID:25596134
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
G
Sh3tc1
SH3 domain and tetratricopeptide repeats 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of SH3TC1 mRNA
CTD
PMID:25596134
NCBI chr14:75,005,691...75,050,001
Ensembl chr14:75,016,875...75,049,995
G
Slc27a2
solute carrier family 27 member 2
decreases expression
ISO
adefovir dipivoxil results in decreased expression of SLC27A2 mRNA
CTD
PMID:25596134
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
G
Slc6a9
solute carrier family 6 member 9
decreases expression
ISO
adefovir dipivoxil results in decreased expression of SLC6A9 mRNA
CTD
PMID:25596134
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
increases expression
ISO
adefovir dipivoxil results in increased expression of SLCO2B1 mRNA
CTD
PMID:25596134
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
G
Smap1
small ArfGAP 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of SMAP1 mRNA
CTD
PMID:25596134
NCBI chr 9:26,250,178...26,342,151
Ensembl chr 9:26,249,978...26,342,170
G
Sulf2
sulfatase 2
increases expression
ISO
adefovir dipivoxil results in increased expression of SULF2 mRNA
CTD
PMID:25596134
NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
adefovir dipivoxil binds to and results in decreased activity of THRA protein
CTD
PMID:25752796
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Tigar
TP53 induced glycolysis regulatory phosphatase
increases expression
ISO
adefovir dipivoxil results in increased expression of TIGAR mRNA
CTD
PMID:25596134
NCBI chr 4:159,927,136...159,946,077
Ensembl chr 4:159,927,139...159,946,029
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
increases expression
ISO
adefovir dipivoxil results in increased expression of TIPARP mRNA
CTD
PMID:25596134
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tnfsf9
TNF superfamily member 9
increases expression
ISO
adefovir dipivoxil results in increased expression of TNFSF9 mRNA
CTD
PMID:25596134
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
G
Tp53
tumor protein p53
affects activity
ISO
adefovir dipivoxil affects the activity of TP53 protein
CTD
PMID:25596134 PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
increases expression
ISO
adefovir dipivoxil results in increased expression of TP53INP1 mRNA
CTD
PMID:25596134
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Trafd1
TRAF type zinc finger domain containing 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of TRAFD1 mRNA
CTD
PMID:25596134
NCBI chr12:35,165,606...35,179,525
Ensembl chr12:35,165,606...35,179,525
G
Triap1
TP53 regulated inhibitor of apoptosis 1
increases expression
ISO
adefovir dipivoxil results in increased expression of TRIAP1 mRNA
CTD
PMID:25596134
NCBI chr12:41,267,534...41,270,053
Ensembl chr12:41,267,549...41,270,042
G
Ube2o
ubiquitin-conjugating enzyme E2O
decreases expression
ISO
adefovir dipivoxil results in decreased expression of UBE2O mRNA
CTD
PMID:25596134
NCBI chr10:101,765,572...101,812,736
Ensembl chr10:101,766,005...101,812,899
G
Yars1
tyrosyl-tRNA synthetase 1
decreases expression
ISO
adefovir dipivoxil results in decreased expression of YARS1 mRNA
CTD
PMID:25596134
NCBI chr 5:141,535,815...141,564,029
Ensembl chr 5:141,535,759...141,563,833
G
Zmat3
zinc finger, matrin type 3
increases expression
ISO
adefovir dipivoxil results in increased expression of ZMAT3 mRNA
CTD
PMID:25596134
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all